Scyllitol clinical trials
Also written ELND005 and scyllo-inositol.
- studies test it
- 5
- open now
- 0
- in phase 3
- 0
- first study started
- 2007
How each study uses scyllitol is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 2012 (2)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2009 | 1 |
| 2012 | 2 |
| 2013 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 5
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 0
Studies
Open first, then newest update. How each study uses scyllitol is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- A 4-Week Safety Study of Oral ELND005 in Young Adults With Down Syndrome Without DementiaCompletedPhase 2OPKO Health, Inc.NCT01791725Written as ELND005How we know
- ELND005 in Patients With Mild to Moderate Alzheimer's DiseaseCompletedPhase 2OPKO Health, Inc.NCT00568776Written as Placebo ControlHow we know
- Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's DiseaseCompletedPhase 2OPKO Health, Inc.NCT01735630Written as ELND005How we know
- ELND005 Long-Term Follow-up Study in Subjects With Alzheimer's DiseaseCompletedPhase 2OPKO Health, Inc.NCT00934050Written as ELND005 (scyllo-inositol)How we know
- Safety and Efficacy Study of ELND005 as an Adjunctive Maintenance Treatment in Bipolar I DisorderTerminatedPhase 2OPKO Health, Inc.NCT01674010Written as ELND005How we know
Codes
What other systems call scyllitol · ClinicalTrials.gg INT002448
- MeSH (NLM) C009217scyllitolOne source NLM
- UNII (FDA) 1VS4X81277SCYLLO-INOSITOLConfirmed FDA, NLM
- NCI Thesaurus C122987ScyllitolOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C009217 | scyllitol | One source NLM |
| UNII (FDA) | 1VS4X81277 | SCYLLO-INOSITOL | Confirmed FDA, NLM |
| NCI Thesaurus | C122987 | Scyllitol | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.